Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 1;24(1):10.
doi: 10.1186/s12929-017-0317-0.

Escape from IFN-γ-dependent immunosurveillance in tumorigenesis

Affiliations
Review

Escape from IFN-γ-dependent immunosurveillance in tumorigenesis

Chiou-Feng Lin et al. J Biomed Sci. .

Abstract

Immune interferon (IFN), also known as IFN-γ, promotes not only immunomodulation but also antimicrobial and anticancer activity. After IFN-γ binds to the complex of IFN-γ receptor (IFNGR) 1-IFNGR2 and subsequently activates its downstream signaling pathways, IFN-γ immediately causes transcriptional stimulation of a variety of genes that are principally involved in its biological activities. Regarding IFN-γ-dependent immunosurveillance, IFN-γ can directly suppress tumorigenesis and infection and/or can modulate the immunological status in both cancer cells and infected cells. Regarding the anticancer effects of IFN-γ, cancer cells develop strategies to escape from IFN-γ-dependent cancer immunosurveillance. Immune evasion, including the recruitment of immunosuppressive cells, secretion of immunosuppressive factors, and suppression of cytotoxic T lymphocyte responses, is speculated to be elicited by the oncogenic microenvironment. All of these events effectively downregulate IFN-γ-expressing cells and IFN-γ production. In addition to these extrinsic pathways, cancer cells may develop cellular tolerance that manifests as hyporesponsiveness to IFN-γ stimulation. This review discusses the potential escape mechanisms from IFN-γ-dependent immunosurveillance in tumorigenesis.

Keywords: Cancer; Escape; Hyporesponsiveness; IFN-γ; Immunosurveillance.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Immune surveillance and escape from IFN-γ-dependent anticancer activity. CCL: CC chemokine ligands; CXCL: CXC chemokine ligands; CTL: cytotoxic T lymphocytes; CTLA: cytotoxic T-lymphocyte-associated protein; IDO: indoleamine-pyrrole 2,3-dioxygenase; IFN: interferon; IFNGR: IFN-γ receptors; IL: interleukin; IRF: IFN-regulating factors; JAK: Janus kinase; MDSC: myeloid-derived suppressor cell; MHC: major histocompatibility complex; NK: natural killer; PD-L1: programmed death ligand 1; PGE: prostaglandin E; SHP: src homology-2 containing phosphatase; SOCS: suppressors of cytokine signaling; STAT: signal transducer and activator of transcription; TAM: tumor-associated macrophage; TAP: transporter associated with antigen processing; TGF: transforming growth factor; TNF: tumor necrosis factor; TRAIL: TNF-related apoptosis-inducing ligand; Treg: regulatory T cell

References

    1. Abril E, Mendez RE, Garcia A, Serrano A, Cabrera T, Garrido F, Ruiz-Cabello F. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon. Tissue Antigens. 1996;47(5):391–398. doi: 10.1111/j.1399-0039.1996.tb02574.x. - DOI - PubMed
    1. Abril E, Real LM, Serrano A, Jimenez P, Garcia A, Canton J, Trigo I, Garrido F, Ruiz-Cabello F. Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line. Cancer Immunol Immunother. 1998;47(2):113–120. doi: 10.1007/s002620050511. - DOI - PMC - PubMed
    1. Ahmad M, Rees RC, Ali SA. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother. 2004;53(10):844–854. doi: 10.1007/s00262-004-0540-x. - DOI - PMC - PubMed
    1. Ahn EY, Pan G, Vickers SM, McDonald JM. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int J Cancer. 2002;100(4):445–451. doi: 10.1002/ijc.10516. - DOI - PubMed
    1. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1–9. doi: 10.1016/j.critrevonc.2007.07.004. - DOI - PubMed